Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
Recently a novel subtype of endometrial stromal sarcoma (ESS) defined by recurrent genomic alterations involving BCOR has been described (HGESS‐BCOR).
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
30 April 2020
|
| In: |
The journal of pathology: clinical research
Year: 2020, Volume: 6, Issue: 3, Pages: 178-184 |
| ISSN: | 2056-4538 |
| DOI: | 10.1002/cjp2.165 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/cjp2.165 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/cjp2.165 |
| Author Notes: | Felix KF Kommoss, Kenneth TE Chang, Damian Stichel, Ana Banito, David TW Jones, Christoph E. Heilig, Stefan Fröhling, Felix Sahm, Albrecht Stenzinger, Wolfgang Hartmann, Gunhild Mechtersheimer, Hans-Peter Sinn, Dietmar Schmidt, Friedrich Kommoss, Andreas von Deimling and Christian Koelsche |
| Summary: | Recently a novel subtype of endometrial stromal sarcoma (ESS) defined by recurrent genomic alterations involving BCOR has been described (HGESS‐BCOR). |
|---|---|
| Item Description: | Gesehen am 22.12.2020 |
| Physical Description: | Online Resource |
| ISSN: | 2056-4538 |
| DOI: | 10.1002/cjp2.165 |